Modified SALT Score for Alopecia Areata
NCT04412148 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2020-06-02
Summary
Patchy Alopecia areata was treated by intralesional steroids for 3 months and was evaluated by percentage of involvement, mSALT score and dermoscopy.
Conditions
Interventions
- DRUG
-
Triamcinolone Acetonide
intralesional injection of triamcinolone acetonide every 2 weeks for 6 sessions
- OTHER
-
saline
intralesional injection of saline
Sponsors & Collaborators
-
Kasr El Aini Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- DOUBLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-01-01
- Primary Completion
- 2020-07-01
- Completion
- 2020-08-01
Countries
- Egypt
Study Locations
More Related Trials
-
Topical Calcipotriol Versus Narrowband Ultraviolet B in Treatment of Alopecia Areata
NCT03847441 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Oral Tofacitinib in Moderate to Severe Alopecia Areata, Totalis and Universalis at Tertiary Care Hospital, Karachi.
NCT06278402 ·Status: COMPLETED ·Phase: PHASE3
-
Topical Simvastatin Versus Topical Steroid in Treatment of Alopecia Areata
NCT06399783 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Cryotherapy Versus Steroids In Alopecia Areata:Trichoscopic Evaluation
NCT03473600 ·Status: UNKNOWN ·Phase: PHASE4
-
Intralesional Vitamin D in Alopecia Areata
NCT04660786 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Efficacy of Jessener Solution Versus Intralesional Steroid in Treatment of Alopecia Areata
NCT04964349 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata
NCT01167946 ·Status: COMPLETED ·Phase: PHASE4
-
New Treatment of Alopecia Areata
NCT05594316 ·Status: COMPLETED ·Phase: NA
-
Combined Microneedling With Either 1% Lactic Acid Solution or Vitamin D3 or Triamcinolone Acetonide in The Treatment of Alopecia Areata
NCT06327581 ·Status: RECRUITING ·Phase: NA
-
A Novel Formulation of Sildenafil-loaded Nanocarriers for Treatment of Alopecia Areata
NCT06527729 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Phototoxic Doses of Ultraviolet A for Treatment of Alopecia Areata
NCT01559584 ·Status: COMPLETED ·Phase: NA
-
Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata
NCT00484679 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia Areata
NCT03532958 ·Status: WITHDRAWN ·Phase: PHASE2
-
Comparative Study for Treatment of Alopecia Areata Using Carboxytherapy and Intralesional Steroids
NCT04228029 ·Status: UNKNOWN ·Phase: PHASE4
-
Excimer Light and Topical Steroid in Treatment of Alopecia Areata
NCT04793945 ·Status: UNKNOWN ·Phase: PHASE4
-
Methotrexate Versus Triamcinilone Acetonide in Treatment of Recalcitrant Alopecia Areata
NCT06088147 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Transepidermal Delivery of Triamcinolone Acetonide or Platelet Rich Plasma Using Either Fractional Carbon Dioxide Laser or Microneedling in Treatment of Alopecia Areata
NCT04147845 ·Status: COMPLETED ·Phase: NA
-
A Study to Learn About the Medicine Called Ritlecitinib in Adults With Severe Alopecia Areata in Real-world Settings
NCT07200128 ·Status: COMPLETED
-
Evaluation of Serum Levels of Interlukin-15 and Interlukin-21 in Patients With Alopecia Areata
NCT05910138 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Effect of Topical Calcipotriol Versus Platelet-Rich Plasma
NCT05954104 ·Status: COMPLETED ·Phase: NA
-
Intralesional Steroids in the Treatment of Alopecia Areata
NCT01898806 ·Status: TERMINATED ·Phase: PHASE4
-
Clinical Trial on the Efficacy of Intralesional Triamcinolone Versus Candida Albicans Antigen in Treating Alopecia Areata
NCT06564805 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Combined Microneedling With Methotrexate in Treatment of Alopecia Areata
NCT05485571 ·Status: UNKNOWN ·Phase: NA
-
Combined CO2 Fractional Laser With Bimatoprost 0.03% Treatment of Alopecia Areata
NCT05600673 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of Exosomes Injection in Treatment of Male Androgenetic Alopecia: Clinical and Immunohistochemical Study
NCT07112586 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2